Publications by authors named "Ryosuke Koretomo"

Claim this Profile
T
Two long-term phase 3 studies of enarodustat (JTZ-951) in Japanese anemic patients with chronic kidney disease not on dialysis or on maintenance hemodialysis: SYMPHONY ND-Long and HD-Long studies.
Tadao Akizawa, Masaomi Nangaku, Takuhiro Yamaguchi, Ryosuke Koretomo, Kazuo Maeda

Ther Apher Dial· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 3 Study of Enarodustat (JTZ-951) in Japanese Hemodialysis Patients for Treatment of Anemia in Chronic Kidney Disease: SYMPHONY HD Study.
Tadao Akizawa, Masaomi Nangaku, Takuhiro Yamaguchi, Ryosuke Koretomo, Kazuo Maeda

Kidney Dis (Basel)· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thorough QT/QTc Evaluation of the Cardiac Safety of Enarodustat (JTZ-951), an Oral Erythropoiesis-Stimulating Agent, in Healthy Adults.
Sudhakar M Pai, Hiroyuki Yamada, Robert B Kleiman, Rui Zhuo, Qingtao Mike Huang, Ryosuke Koretomo

Clin Pharmacol Drug Dev· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 3 Study of Enarodustat in Anemic Patients with CKD not Requiring Dialysis: The SYMPHONY ND Study.
Tadao Akizawa, Masaomi Nangaku, Takuhiro Yamaguchi, Ryosuke Koretomo, Kazuo Maeda

Kidney Int Rep· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Mass Balance Study of C-Labeled JTZ-951 (Enarodustat), a Novel Orally Available Erythropoiesis-Stimulating Agent, in Patients With End-Stage Renal Disease on Hemodialysis.
Sudhakar M Pai, Jeffrey Connaire, Hiroyuki Yamada, Seiji Enya, Barbara Gerhardt, Ryosuke Koretomo

Clin Pharmacol Drug Dev· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enarodustat, Conversion and Maintenance Therapy for Anemia in Hemodialysis Patients: A Randomized, Placebo-Controlled Phase 2b Trial Followed by Long-Term Trial.
Tadao Akizawa, Masaomi Nangaku, Takuhiro Yamaguchi, Masanobu Arai, Ryosuke Koretomo

Nephron· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Placebo-Controlled, Randomized Trial of Enarodustat in Patients with Chronic Kidney Disease Followed by Long-Term Trial.
Tadao Akizawa, Masaomi Nangaku, Takuhiro Yamaguchi, Masanobu Arai, Ryosuke Koretomo

Am J Nephrol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors involved in the maturation of murine dendritic cells transduced with adenoviral vector variants.
Naoko Kanagawa, Ryosuke Koretomo, Sayaka Murakami, Fuminori Sakurai, Hiroyuki Mizuguchi

Virology· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis